Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 19 of 19 for “"MmpL3"”.

  1. Structural & biophysical characterisation of M. tuberculosis MmpL3

    … exporter mycobacterial membrane protein large 3 (MmpL3), a member of the resistance-nodulation-division (RND) superfamily. MmpL3 is required for construction of the distinctive Mycobacterium tuberculosis (Mtb) cell envelope; a complex lipid-rich assembly critical to mycobac- terial viability. …

    oxford Repository record for Structural & biophysical characterisation of M. tuberculosis MmpL3 (opens in a new tab)

  2. Design, Synthesis And Evaluation Of Novel Antimycobacterial Compounds Targeting The MmpL3 Transporter Protein.

    … Mycobacterial membrane protein large 3 (MmpL3) is an essential transporter responsible for the translocation of mycolic acids to the outer membrane. Published indole-2-carboxamides with suggested MmpL3 inhibition showed good potency, against whole-cell M. tb, yet had poor aqueous …

    creighton Repository record for Design, Synthesis And Evaluation Of Novel Antimycobacterial Compounds Targeting The MmpL3 Transporter Protein. (opens in a new tab)

  3. Σχεδιασμός και σύνθεση αναλόγων του φαρμάκου SQ109 που αναστέλλουν τον μεταφορέα μονομυκολικής τρεχαλόζης MMPL3 του μυκοβακτήριου της φυματίωσης.

    … προσδιορίστηκε η κρυσταλλική δομή του μεταφορέα MmpL3 συμπλεγμένος με το SQ109 η οποία αποτελεί εφαλτήριο για τον σχεδιασμό φαρμακομορίων με βάση τη δομή του υποδοχέα. Χρησιμοποιώντας αυτή τη δομή σχεδιάσαμε και συνθέσαμε νέα ανάλογα του SQ109, AK108-AK118, ως μέρος ενός τρέχοντος έργου για την …

    athens Repository record for Σχεδιασμός και σύνθεση αναλόγων του φαρμάκου SQ109 που αναστέλλουν τον μεταφορέα μονομυκολικής τρεχαλόζης MMPL3 του μυκοβακτήριου της φυματίωσης. (opens in a new tab)

  4. Purification, Mechanism, and Biochemical Interactions of the Essential Mycolic Acid Transporters MmpL3 from Mycobacterium tuberculosis, and CmpL1 from Corynebacterium glutamicum.

    … function of the essential membrane transporter MmpL3. The role of MmpL3 as a mycolic acid transporter has since been validated, and MmpL3 has been pursued as a novel pharmacological target. Despite the significance of this discovery, the exact mechanism by which MmpL3 transports mycolic acids …

    oklahoma-thes Repository record for Purification, Mechanism, and Biochemical Interactions of the Essential Mycolic Acid Transporters MmpL3 from Mycobacterium tuberculosis, and CmpL1 from Corynebacterium glutamicum. (opens in a new tab) Restricted access

  5. CHEMICAL BIOLOGY AND GENETIC STUDIES TARGETING THE MYCOBACTERIAL CELL ENVELOPE

    … Over the last decade, the lipid flippase MmpL3 has been identified as a potential drug candidate based on its essential nature for cell viability and repeated identification as the lead target of small molecule inhibitors of Mtb growth. Using a combined untargeted and targeted whole cell …

    msu Repository record for CHEMICAL BIOLOGY AND GENETIC STUDIES TARGETING THE MYCOBACTERIAL CELL ENVELOPE (opens in a new tab)

  6. Structure-based drug discovery research on the MmpL3 transporter of mycobacterium tuberculosis and the M2 proton channel of influenza A virus

    … cell wall biosynthesis by inhibiting the MmpL3 transporter. It also has activity against bacteria and protozoan parasites that lack MmpL3, where it can act as an uncoupler, targeting lipid membranes and Ca2+ homeostasis. Here, we showed using molecular dynamics (MD) simulations that the …

    greece Repository record for Structure-based drug discovery research on the MmpL3 transporter of mycobacterium tuberculosis and the M2 proton channel of influenza A virus (opens in a new tab)

  7. INTEGRATED COMPUTATIONAL APPROACHES: ELUCIDATING MOLECULAR MECHANISMS OF PATHOGENIC PROTEINS AND DESIGNING NOVEL INHIBITORS AGAINST MYCOBACTERIUM TUBERCULOSIS AND SARS-COV-2

    … 3, we concentrate on the characterization of MmpL3, a crucial Resistance Nodulation Division (RND) transporter in MtB. Through molecular dynamics simulations, we gain a comprehensive understanding of MmpL3's structural dynamics and conformational functionality. A significant aspect of this …

    rowan Repository record for INTEGRATED COMPUTATIONAL APPROACHES: ELUCIDATING MOLECULAR MECHANISMS OF PATHOGENIC PROTEINS AND DESIGNING NOVEL INHIBITORS AGAINST MYCOBACTERIUM TUBERCULOSIS AND SARS-COV-2 (opens in a new tab)

  8. Design and Identification of Novel Agents to Tackle Antimicrobial Resistance in Tuberculosis

    … derivatives, designed as hybrids of the MmpL3 inhibitor antitubercular agents BM212 and SQ109, have been synthesised and evaluated against susceptible and drug-resistant mycobacteria strains. Several derivatives displayed submicromolar activity against M. tuberculosis strains while …

    kings Repository record for Design and Identification of Novel Agents to Tackle Antimicrobial Resistance in Tuberculosis (opens in a new tab) Download PDF for Design and Identification of Novel Agents to Tackle Antimicrobial Resistance in Tuberculosis (opens in a new tab)

  9. Optimization of N-(1-Adamantyl)-3-Aryl Acetamides as Novel Antimycobacterial Agents

    … needed. Mycobacteria membrane protein large 3 (MmpL3) is a transmembrane protein responsible for shuttling mycolic acids from the cytosol to the outer membrane of mycobacteria, and its inhibition results in mycobacterial growth inhibition. Previously, urea- and indole-based MmpL3 inhibitors have …

    creighton Repository record for Optimization of N-(1-Adamantyl)-3-Aryl Acetamides as Novel Antimycobacterial Agents (opens in a new tab)

  10. Molecular mechanisms of cell wall lipid transport in Mycobacterium tuberculosis

    … the mechanism of three transport systems: MmpL3, MmpL7 and DrrABC (encoded by mmpL3, mmpL7 and drrABC genes) using molecular modelling, genetics and lipid and protein biochemistry. mmpL3 is essential for trehalose monomycolate (TMM) transport. While mmpL7 is required for the export of two …

    birmingham Download PDF for Molecular mechanisms of cell wall lipid transport in Mycobacterium tuberculosis (opens in a new tab)

  11. Inhibitors of mycobacterium tuberculosis DosRST signaling and persistence

    … Mtb by targeting the mycolic acid transporter MmpL3. MmpL3 is an essential protein that functions to transport trehalose monomycolate across mycomembranes for trehalose dimycolate biosynthesis. HC2091 is bactericidal against Mtb in a dose- and time- dependent manner in vitro. It also has …

    msu Repository record for Inhibitors of mycobacterium tuberculosis DosRST signaling and persistence (opens in a new tab)

  12. Σύνθεση νέων αναλόγων του φαρμακομορίου SQ109 κατά παθογόνων μικροοργανισμών

    … της κρυσταλλικής δομής του μεταφορέα MmpL3 σε σύζευξη με την ένωση SQ109, διάφορες ερευνητικές ομάδες έχουν προχωρήσει στο σχεδιασμό μορίων σύμφωνα με τη δομή του υποδοχέα. Επίσης φαρμακολογικά δεδομένα έχουν δείξει ότι η βένζυλο και η φαινυλο-υποκατάσταση στην δύο θέση του …

    athens Repository record for Σύνθεση νέων αναλόγων του φαρμακομορίου SQ109 κατά παθογόνων μικροοργανισμών (opens in a new tab)

  13. Σχεδιασμός και σύνθεση νέων αρωματικών αδαμαντανικών ουριών, αμιδοξιμών και αμιδινών με πιθανή φαρμακολογική δράση

    … (sEH), η διαμεμβρανική μυκοβακτηριακή πρωτεΐνη MmpL3 και τα πρωτόζωα Trypanosoma brucei και Trypanosoma cruzi, σύμφωνα με προηγούμενα ερευνητικά αποτελέσματα. Συγκεκριμένα, οι C-1 και C-2 υποκατεστημένες αδαμαντανικές αρωματικές ουρίες 7a, 9a, 13a, 19a, 24a, 26a προέκυψαν από τη συμπύκνωση του …

    athens Repository record for Σχεδιασμός και σύνθεση νέων αρωματικών αδαμαντανικών ουριών, αμιδοξιμών και αμιδινών με πιθανή φαρμακολογική δράση (opens in a new tab)

  14. Molecular tools to unravel the mechanism of action of M. tuberculosis phenotypic hits

    … series inhibitors of the transporter protein MmpL3; human diacylglycerol transferase (DGAT1) inhibitors and human kinase inhibitors. Inhibitors of MmpL3 are notoriously structurally diverse, and it is not uncommon for them to have alternative targets. Using chemoproteomic profiling the BM212 …

    birmingham Download PDF for Molecular tools to unravel the mechanism of action of M. tuberculosis phenotypic hits (opens in a new tab)

  15. Design, Synthesis, and Evaluation of Novel Antimycobacterial Agents With Enhanced Pharmacokinetic Profiles

    … Mycobacterial membrane protein large 3 (MmpL3) is an essential transporter protein that translocates mycolic acids as trehalose monomycolates (TMM), an ester comprising trehalose sugar and a mycolic acid, across the plasma membrane. The inhibition of this novel target obstructs the TMM …

    creighton Repository record for Design, Synthesis, and Evaluation of Novel Antimycobacterial Agents With Enhanced Pharmacokinetic Profiles (opens in a new tab)

  16. Design, Synthesis and biological evaluation of drug-like molecules bearing an adamantane moiety against targets of therapeutic interest in human deseases

    … membrane protein large transporter type 3 (MmpL3) transporter to block cell wall biosynthesis. It also exhibits activity against bacteria and protozoan parasites that lack MmpL3, where it can function as an uncoupler, focusing on lipid membranes and Ca2+ homeostasis. In this study, we …

    greece Repository record for Design, Synthesis and biological evaluation of drug-like molecules bearing an adamantane moiety against targets of therapeutic interest in human deseases (opens in a new tab)

  17. Aerosolizable Drug-Loaded SPIONs for Treatment and Diagnosis of Pulmonary Tuberculosis

    … evaporation method, with Ethambutol and a novel MmpL3 inhibitor, N-(adamantyl)-1H-indole-2-carboxamide (N2), incorporated as model therapeutic agents. The resulting nanoparticles were characterized by dynamic light scattering (DLS), transmission electron microscopy (TEM), powder X-ray diffraction …

    creighton Repository record for Aerosolizable Drug-Loaded SPIONs for Treatment and Diagnosis of Pulmonary Tuberculosis (opens in a new tab)

  18. Enhancing Pulmonary Delivery of Novel Anti-Mycobacterial Compounds

    Tuberculosis (TB), a granulomatous disease primarily affecting the lungs, is caused by the bacterial pathogen Mycobacterium tuberculosis. Despite its treatability, the current regimen faces formidable challenges, principally patient adherence due to the prolonged treatment duration - six months for …

    creighton Repository record for Enhancing Pulmonary Delivery of Novel Anti-Mycobacterial Compounds (opens in a new tab)